Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

Ibogamine congeners for addiction

April 15, 1997

Allelix and Pharm-Eco create partnership

April 10, 1997

PDL and Teijin agreement for MAb to E. coli toxin

April 9, 1997

Genes involved in marijuana abuse

April 8, 1997

Pharmacia & Upjohn purchases U.S. manufacturing rights for Cygnus' Nicotrol

March 10, 1997

Selective nAChR ligands prepared by Novo Nordisk

Feb. 27, 1997

Sano begins pivotal trials with smoking cessation product

Feb. 26, 1997

Allelix and Pharm-Eco form joint venture

Jan. 27, 1997

NIH seeks licensees for dopamine reuptake inhibitors

Jan. 23, 1997

Altus receives grant for nerve agent neutralization

Jan. 21, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 14, 2025.
European VCs optimistic for med-tech exit opportunities in 2025
BioWorld MedTech
To say that European investors are optimistic about the outlook for the med-tech sector in 2025 is an understatement. A couple of companies are already listed on...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for February 14, 2025
European VCs bullish on med-tech investments in 2025
BioWorld MedTech
European companies looking for capital should find the fundraising environment more favorable in 2025. Private med-tech financings in January totaled about $2...
Kura/Kyowa Kirin’s ziftomenib hits phase II endpoints in AML
BioWorld
Kura Oncology Inc. and Kyowa Kirin Co. Ltd.’s selective oral menin inhibitor, ziftomenib, met the primary endpoints in the phase II registrational Komet-001 trial...